INVESTIGATIONAL DRUG SERVICES IN THE HOSPITAL Sheree Miller, Pharm.D. University of Washington Medical Center 1-13-04.

Slides:



Advertisements
Similar presentations
Medication Management
Advertisements

Regulatory Clinical Trials Clinical Trials. Clinical Trials Definition: research studies to find ways to improve health Definition: research studies to.
Clinical Trials What Are They and When Are They Right For You? Maura N. Dickler Assistant Attending Physician Breast Cancer Medicine Service Memorial Sloan-Kettering.
What is involved? What are your responsibilities? May 2013: Research Institute, Clinical Research Administration Investigational New Drug Application (IND)
Single-Patient Use of Investigational Drugs and Biologic Products for Treating Cancer Grant Williams, M.D. Medical Team Leader DODP/CDER/FDA.
Research & Pharmacy Profession PHCL 311 Hadeel Al-Kofide M.Sc.
Single Use Expanded Access IND/IDE: FDA and IRB Requirements Before and After Use IRB Webinar October 9,2014.
Clinical Trials — A Closer Look. The Food and Drug Administration (FDA) is the main consumer watchdog for numerous products: Drugs and biologics (prescription.
Modified Megestrol The Clinical Trials by : Carolina R. Akib
Clinical Trials Medical Interventions
Pharmaceutical Development and Review Process Rev. 10/21/2014 APGO Interaction with Industry: A Medical Student Guide.
Cancer Clinical Trials:
+ Drug Development and Review Process. + Objectives Learn the processes involved in drug discovery and development Define the phases involved in FDA drug.
11/11/04 Clinical Research and Development in the Pharmaceutical and Biotechnology Industry Robert Anderson, MHA, CCRA, CCRCP Director, Clinical Trials.
Clinical Trials Scientific Aspects AND Legal & Procedural Aspects M K Unnikrishnan [Aug 2006]
Career Opportunities for PharmDs in the Pharmaceutical Industry: Research & Development.
Clinical Pharmacy’s Role in Research Trials Sheree Miller Pharm.D. Investigational Drug Service University of Washington Medical Center.
Investigational New Drug Application 21 CFR Part 312 A Review for OCRA US RAC Study Group September 2005 Ginger Clasby, MS Promedica International
Stages of drug development
Pharmacy and Therapeutics Committee
Coordinator University Clinical Research Pharmacy Investigational Drug Service (IDS) Marjorie Shaw Phillips, MS, RPh, FASHP Clinical Research Pharmacist.
February 2008 William Petros, Pharm.D., FCCP
Merrell Lim, Pharm.D. Investigational Drug Services Pharmacist
Yesterday, today, and tomorrow
Testing People Scientifically.  Clinical trials are research studies in which people help doctors and researchers find ways to improve health care. Each.
Jasper Ogwal-Okeng Gulu University Research Workshop 3 rd -6 th March 08.
Clinical Trials Amir Zarrinhaghighi
Role of the Oncology Research Team Carmen B. Jacobs, RN, OCN, CCRP.
Stefan Franzén Introduction to clinical trials.
Investigational New Drug Application (IND)
When do I need an IND ? FDA Guidance for Industry – Investigation New Drug Applications (INDs) - Determining Whether Human Research Studies Can Be Conducted.
Investigational Drugs Drug Laws, Drug Approval Process.
INDs : Does My Study Need One? Edith Paal UAMS Office of Research Compliance August 22, 2003.
CHEE DRUG PRODUCT DEVELOPMENT u Drug ä agent intended for use in the diagnosis, mitigation, treatment, cure, or prevention of disease in man or animals.
Investigational Drugs in the hospital. + What is Investigational Drug? Investigational or experimental drugs are new drugs that have not yet been approved.
RESEARCH PROGRAM UPDATE Sarah Castro, MPH Senior Research Support Liaison.
CHP400: Community Health Program - lI Research Methodology STUDY DESIGNS Observational / Analytical Studies Present: Disease Past: Exposure Cross - section.
CLINICAL TRIALS IN NEW DRUG DEVELOPMENT Michael A Ross,M.D. President CPL Inc.
1/33.  What is INDA ?  Types of INDAs  Objectives of INDAs  Format & Contents of an INDA  IND Safety reports  IND Annual Reports  IND Review Process.
Emtenan AlHarbi,Mcs Clinical pharmacist
The New Drug Development Process (www. fda. gov/cder/handbook/develop
The FDA: Basic Facts It takes 12 to 15 years to develop a single drug Only 1 in 10,000 potential medications makes it completely through the process Only.
بسم الله الرحمن الرحيم جامعة أم درمان الإسلامية كلية الطب و العلوم الصحية - قسم طب المجتمع مساق البحث العلمي / الدفعة 21 Basics of Clinical Trials.
Overview of Gene Therapy Surveillance Inspections Joseph P Salewski, Chief Bioresearch Monitoring Branch CBER.
Process of FDA New Drug Approval: 1- New Compound with promising preclinical data 2- Sponsor applies to FDA for an IND (Investigational New Drug Application)
Inside Clinical Trials ® ALL RIGHTS RESERVED. What is a clinical trial? ALL RIGHTS RESERVED.
Investigational Devices and Humanitarian Use Devices June 2007.
MEDICATION MANAGEMENT P&T COMMITTEE AND FORMULARY MANAGEMENT EMTENAN ALHARBI, Msc CLINICAL PHARMACIST.
“Journey of a Drug” From Test Tube TO Prescribing Physician.
Pharmacy & The IRB Linda Sailor, BS, PharmD Rania Sadaka, BS, PharmD May 2015.
Clinical Trials - PHASE II. Introduction  Important part of drug discovery process  Why important??  Therapeutic exploratory trial  First time in.
Clinical Trials.
Study Development and Design Suzanne Adams RN MPH Director, Clinical Operations Jefferson Clinical Research Institute.
Drug Development Process Stages involved in Regulating Drugs
CLINICAL TRIALS.
Is a Clinical Trial Right for Me?
The Stages of a Clinical Trial
Drug Discovery &Development
Regulatory– Terms & Definitions רגולציה - מונחים והגדרות
Schedule 2 Drugs Henderson.
Clinical Trials — A Closer Look
Prof. Dr. Basavaraj K. Nanjwade
Clinical Trials Medical Interventions
Bozeman Health Clinical Research
Non For Profit Model for Rare Disease Therapy Development
Clinical Trials.
Speeding access to therapies
Streamlining IRB Procedures for Expanded Access
Drug Development Stages
Research, Experimentation, & Clinical Trials
Presentation transcript:

INVESTIGATIONAL DRUG SERVICES IN THE HOSPITAL Sheree Miller, Pharm.D. University of Washington Medical Center

What is an Investigational Drug new drugs old drugs- new indications, new combinations, new components investigational use of commercially available drugs

Preclinical Trials acquisition of new agent. screening for activity, formulation and production of agent, toxicology

Investigational New Drug Application (IND) may be filed by: innovator/manufacturer physician academic medical center governmental agency -NIH, NCI-

Phase I small numbers healthy volunteers toxicity kinetics, administration route safe dose range (MTD)

Phase II treatment or prophylaxis of a specific disease demonstrate safety and efficacy toxicity- first controlled trials

Phase III expanded clinical trials compare to existing standard therapy determine optimum dose and schedule accumulate information to establish drug effectiveness for specific indications and populations at risk from its use.

If IND is successful, file New Drug Application (NDA)

Institutional Review Board University of Washington Human Subjects Review Board appointed by institution- Membership: at least 5 members- men and women, more than one profession, one non-scientist, one not associated with the institution FDA holds this board responsible to protect the welfare and rights of human subjects in research

Institutional Review Board Protocols and Informed consents for study subjects are reviewed and approved by the IRB

Informed Consents Informed Consents should contain information about the treatment or drug and be written in lay language. Objectives of clinical trial should be explained, including risks and benefits, and any alternative therapies available. Outlines the responsibility of the investigator to keep the subject informed about additional information that becomes available as the study progresses

Non Research Use of Investigational agents Investigational agents may be used emergently or not under the format of a clinical trial. Informed consent and IRB approval or notification is required for emergent use.

Treatment INDs to make certain investigational new drugs available to desperately ill patients before the FDA approves them for marketing. These INDs are for pre-approved protocols using the drug in a specific treatment and disease. -no comparable drug available - immediately life threatening or serious disease - drug under active investigation - drug shows promise of therapeutic benefit

Compassionate Use allows the use of a drug for patients who are desperately ill, do not qualify for a clinical trial, or when clinical trial is not available.

Pharmacy Based Investigational Drug Service FDA vs JCAHO Requirements ASHP Guidelines on Clinical Drug Research

Pharmacy Based Investigational Drug Service Basic Activities: registration of drug's use in hospital procurement storage preparing dispensing maintenance of records Provision of drug information

Pharmacy Based Investigational Drug Service Administrative responsibilities Reordering Investigational Drugs Disposal of Used or Unused drug Computerization of drug ordering and control Billing for IDS Services

Pharmacy Based Investigational Drug Service Pharmaceutical Care IRB Membership Pharmacotherapeutic monitoring of invest. therapy Patient counseling and education Data manager Adverse Drug Reaction Reporting Staff development and inservicing education

Pharmacy Based Investigational Drug Service Research and Development Activities: Protocol development- especially drug delivery and monitoring Single and double blind studies Randomization Pharmaceutical Research- –Formulation, Development Preparation of dosage forms Drug analysis & quality control

Pharmacy Based Investigational Drug Service Benefits of Pharmacy Based Investigational Drug Service to the hospital to the nurses to the investigators to the sponsors to the patients